Immune-mediated Engagement of T Regulatory Cells with Tumor Cells Results in Trogocytosis and Tumor Cell Killing.
Erbe, A. K.; Feils, A. S.; Gao, A.; VandenHeuvel, S.; Boyenga, S.; Hampton, A.; Heck, M.; Zaborek, J.; Spiegelman, D.; Tsarovsky, N.; Hoefges, A.; Pieper, A. A.; Carlson, P. M.; Felder, M.; Patel, R. B.; Gillies, S. D.; Heaton, A.; Morris, Z.; Dinh, H. Q.; Rakhmilevich, A. L.; Sondel, P. M.
Show abstract
Despite advances in treatment, >50% of patients with advanced melanoma are unresponsive to current therapies. Using the B78-D14 melanoma model (GD2+/MHC-I-/MHC-II+), we can cure mice with a regimen that includes radiation therapy (RT) in combination with immunocytokine (IC; anti-GD2 monoclonal antibody linked to IL-2) while establishing immunological memory. We interrogated the role of T cells in the antitumor and memory responses following RT+IC. We show a requirement for CD4, but not CD8 T cells, to achieve both the initial and memory responses. Upon IC-induced cell-cell contact, subsets of CD4 T cells, including Foxp3 T regulatory cells, trogocytose GD2 from tumor cells, acquire cytotoxic granules, and kill tumor cells. These results were confirmed using human tumor cell lines. These findings reveal that CD4 T regulatory cells, upon immunologically-induced binding to tumor cells, can trogocytose tumor antigens and directly kill tumor cells, redefining their potential role in antitumor immunity.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Intratumor Childhood Vaccine-Specific CD4+ T cell Recall Coordinates Antitumor CD8+ T cells and Eosinophils 98%
- Tumor-Specific CD8+ T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes 98%
- Distinct sets of molecular characteristics define tumor-rejecting neoantigens 97%
Similar papers in this journal
- Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor resistant HER2-positive breast cancer 98%
- Rapid establishment of a tumor-retained state curtails the contribution of conventional NK cells to anti-tumor immunity in solid cancers 97%
- A single cell atlas reveals distinct immune landscapes in transplant and primary tumors that determine response or resistance to immunotherapy 97%
Similar papers in this journal
- IL-3-driven T cell-basophil crosstalk enhances anti-tumor immunity 97%
- Microenvironmental correlates of immune checkpoint inhibitor response in human melanoma brain metastases revealed by T cell receptor and single-cell RNA sequencing 97%
- Clonal spreading of tumor-infiltrating T cells underlies the robust antitumor immune responses 97%
Similar papers in this journal
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 98%
- Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells 97%
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 96%
Similar papers in this journal
- Cell lineage as a predictor of immune response in neuroblastoma 96%
- Metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization 95%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.